Role of amyloid precursor protein in the mechanisms of neurodegeneration in Alzheimer's diseaseMASLIAH, E.Laboratory investigation. 1997, Vol 77, Num 3, pp 197-209, issn 0023-6837Article

In vivo modeling of HIV-1 mediated neurodegenerationMASLIAH, E.The American journal of pathology. 1996, Vol 149, Num 3, pp 745-750, issn 0002-9440Article

Evidence for neuroprotective effects of acidic fibroblast growth factor in Alzheimer diseaseTHORNS, V; MASLIAH, E.Journal of neuropathology and experimental neurology. 1999, Vol 58, Num 3, pp 296-306, issn 0022-3069Article

Lewy bodies, Alzheimer pathology and APP mutationMASLIAH, E; SAITOH, T.Neuroscience letters. 1994, Vol 180, Num 2, pp 292-293, issn 0304-3940Article

Synaptic and dendritic pathology in murine retroviral encephalitisNAGRA, R. M; MASLIAH, E; WILEY, C. A et al.Experimental neurology (Print). 1993, Vol 124, Num 2, pp 283-288, issn 0014-4886Article

SIMILAR PATTERN OF PERIPHERAL NEUROPATHY IN MOUSE MODELS OF TYPE 1 DIABETES AND ALZHEIMER'S DISEASEJOLIVALT, C. G; CALCUTT, N. A; MASLIAH, E et al.Neuroscience. 2012, Vol 202, pp 405-412, issn 0306-4522, 8 p.Article

Cortical Lewy body-containing neurons are pyramidal cells : laser confocal imaging of double-immunolabeled sections with anti-ubiquitin and SMI32WAKABAYASHI, K; HANSEN, L. A; MASLIAH, E et al.Acta neuropathologica. 1995, Vol 89, Num 5, pp 404-408, issn 0001-6322Article

Atypical diffuse lewy body disease with neuritic abnormalitiesREYES, E; GAMBOA, A; MASLIAH, E et al.Clinical neuropathology. 1993, Vol 12, Num 6, pp 330-334, issn 0722-5091Article

The synaptic organization of the neocortex in Alzheimer's diseaseMASLIAH, E; MILLER, A; TERRY, R. D et al.Medical hypotheses. 1993, Vol 41, Num 4, pp 334-340, issn 0306-9877Article

nNOS expressing neurons in the entorhinal cortex and hippocampus are affected in patients with Alzheimer's diseaseTHORNS, V; HANSEN, L; MASLIAH, E et al.Experimental neurology (Print). 1998, Vol 150, Num 1, pp 14-20, issn 0014-4886Article

Subpial vacuolar myelopathy after intrathecal ketamine : report of a caseKARPINSKI, N; DUNN, J; HANSEN, L et al.Pain (Amsterdam). 1997, Vol 73, Num 1, pp 103-105, issn 0304-3959Article

Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantineTOGGAS, S. M; MASLIAH, E; MUCKE, L et al.Brain research. 1996, Vol 706, Num 2, pp 303-307, issn 0006-8993Article

Alterations in glutamate receptor 2/3 subunits and amyloid precursor protein expression during the course of Alzheimer's disease and Lewy body variantTHORNS, V; MALLORY, M; HANSEN, L et al.Acta neuropathologica. 1997, Vol 94, Num 6, pp 539-548, issn 0001-6322Article

Synapse alterations in the hippocampal-entorhinal formation in Alzheimer's disease with and without Lewy body diseaseWAKABAYASHI, K; HONER, W. G; MASLIAH, E et al.Brain research. 1994, Vol 667, Num 1, pp 24-32, issn 0006-8993Article

Amyloid precursor protein is localized in growing neurites of neonatal rat brainMASLIAH, E; MALLORY, M; NIANFENG GE et al.Brain research. 1992, Vol 593, Num 2, pp 323-328, issn 0006-8993Article

Altered protein tyrosine phosphorylation in Alzheimer's diseaseSHAPIRO, I. P; MASLIAH, E; SAITOH, T et al.Journal of neurochemistry. 1991, Vol 56, Num 4, pp 1154-1162, issn 0022-3042, 9 p.Article

Thalamic nuclei in Alzheimer disease: evidence against the cholinergic hypothesis of plaque formationMASLIAH, E; TERRY, R; BUZSAKI, G et al.Brain research. 1989, Vol 493, Num 2, pp 240-246, issn 0006-8993Article

An antiaggregation gene therapy strategy for Lewy body disease utilizing β-synuclein lentivirus in a transgenic modelHASHIMOTO, M; ROCKENSTEIN, E; MANTE, M et al.Gene therapy (Basingstoke). 2004, Vol 11, Num 23, pp 1713-1723, issn 0969-7128, 11 p.Article

Blood levels of alpha-1-antichymotrypsin and risk factors for Alzheimer's disease : Effects of gender and apolipoprotein E genotypeLICASTRO, F; MASLIAH, E; PEDRINI, S et al.Dementia and geriatric cognitive disorders. 2000, Vol 11, Num 1, pp 25-28, issn 1420-8008Article

E4 allele dosage does not predict cholinergic activity or synapse loss in Alzheimer's diseaseCOREY-BLOOM, J; TIRABOSCHI, P; HANSEN, L. A et al.Neurology. 2000, Vol 54, Num 2, pp 403-406, issn 0028-3878Article

A role for apoE in regulating the levels of α-1-antichymotrypsin in the aging mouse brain and in Alzheimer's diseaseLICASTRO, F; CAMPBELL, I. L; KINCAID, C et al.The American journal of pathology. 1999, Vol 155, Num 3, pp 869-875, issn 0002-9440Article

Alternative splicing patterns of CYP2D genes in human brain and neurodegenerative disordersWOO, S.-I; HANSEN, L. A; YU, X et al.Neurology. 1999, Vol 53, Num 7, pp 1570-1572, issn 0028-3878Article

Differential neurotrophic effects of apolipoprotein E in aged transgenic miceVEINBERGS, I; MALLORY, M; MANTE, M et al.Neuroscience letters. 1999, Vol 265, Num 3, pp 218-222, issn 0304-3940Article

Abnormal distribution of the non-aβ component of Alzheimer's disease amyloid precursor/α-synuclein in Lewy body disease as revealed by Proteinase K and formic acid pretreatmentTAKEDA, A; HASHIMOTO, M; MALLORY, M et al.Laboratory investigation. 1998, Vol 78, Num 9, pp 1169-1177, issn 0023-6837Article

Differences in a dinucleotide repeat polymorphism in the tau gene between Caucasian and Japanese populations : implication for progressive supranuclear palsyCONRAD, C; AMANO, N; KATZMAN, R et al.Neuroscience letters. 1998, Vol 250, Num 2, pp 135-137, issn 0304-3940Article